Trial intelligence / Profile preview

Postpartum Vildagliptin in Women with Insulin‑treated Gestational Diabetes

2007-000634-39Phase 2Active

Sponsor
Forschergruppe Diabetes
Start
Mar 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (T2DM) comparing Vildagliptin with Placebo (2 arms). Primary endpoint: Incidence of type 2 diabetes mellitus. Started Mar 2009; status: active.

02

Drugs

vildagliptin
03

Conditions

gestational diabetes mellitus (GDM)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2007-000634-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-000634-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call